As also previously demonstrated by Safford et al (2004), patients who demonstrated improvement in biochemical parameters (serum chromogranin A or 24 h urine 5HIAA) or decreased tumour burden on follow up radiological scans post-131I-MIBG therapy showed no statistically significant differences in survival. The gene discussed is CHGA; the disease is neoplasm.